Myfortic 180 mg (Mycophenolic Acid (Mycophenolate Sodium) TABLET (ENTERIC-COATED)) 180 MG

MYFORTIC 180 MG is an enteric-coated tablet containing mycophenolic acid (mycophenolate sodium). It is commonly used for immunosuppression in transplant patients. This medication helps prevent organ rejection by suppressing the immune system.

Strength

180 MG

Pack Size

120

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

MYFORTIC 180 MG is primarily used to prevent organ rejection in patients who have undergone kidney, heart, or liver transplants. It works by suppressing the immune system to reduce the risk of the body rejecting the transplanted organ. This medication is often prescribed in combination with other immunosuppressants to enhance effectiveness. What is MYFORTIC used for? It is used for immunosuppression in transplant patients to help maintain organ function post-surgery.

Side Effects

Common effects of MYFORTIC 180 MG may include gastrointestinal issues such as diarrhea, nausea, and vomiting. Some users may also experience fatigue, headache, or infections. These effects vary among individuals and are not experienced by everyone who takes the medication.

Precautions & Warnings

MYFORTIC 180 MG should be handled with care, especially by pregnant women or those planning to become pregnant, as it can cause harm to an unborn baby. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Regular monitoring may be required to assess the medication's impact on the body.

Avoid Interactions

MYFORTIC 180 MG may interact with other medications, including antacids, cholestyramine, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while taking this medication, as it can increase the risk of side effects.

References

Frequently Asked Questions

MYFORTIC 180 MG is used to prevent organ rejection in transplant patients by suppressing the immune system.

MYFORTIC 180 MG should be taken orally, with or without food, as directed by a healthcare professional.

Common side effects may include diarrhea, nausea, vomiting, fatigue, headache, and infections.

MYFORTIC 180 MG should be avoided during pregnancy due to potential harm to the unborn baby.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.